Apollomics Inc. (APLM)
(Delayed Data from NSDQ)
$0.16 USD
-0.01 (-3.66%)
Updated Oct 4, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
APLM 0.16 -0.01(-3.66%)
Will APLM be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for APLM based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for APLM
12 Health Care Stocks Moving In Monday's After-Market Session
Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024
Apollomics presents Vebreltinib data in patients with NSCLC
Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Apollomics GAAP EPS of -$0.38